Using RWE to Best Understand Your Patient Population: Diversity & Inclusion Strategies

Time: 9:30 am
day: Day Two


  • Understanding the recent FDA guidance recommending the prospective development of a diversity plan to ensure adequate representation of racial and ethnic subgroups in clinical trials
  • Leveraging RWE to define diversity enrolment goals, determine protocol feasibility, and identify clinical sites with a diverse patient population
  • Utilizing RWE in the post-marketing setting to complement clinical trial findings and support post-marketing requirements or commitments for safety and efficacy data in a diverse patient population